全球静脉注射 (IV) 解决方案市场 - 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球静脉注射 (IV) 解决方案市场 - 行业趋势和 2029 年预测

  • Pharmaceutical
  • Upcoming Report
  • Feb 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

全球静脉 (IV) 溶液市场,按类型(部分肠外营养、全肠外营养)、溶液(盐水、葡聚糖、乳酸林格氏液、氨基酸、维生素和矿物质、肝素和微量元素、混合溶液)、袋类型(大容量袋、小容量袋)、人口统计(成人、儿科、老年人)、应用(基础 IV 溶液、营养 IV 溶液、血液 IV 溶液、药物 IV 溶液、灌溉 IV 溶液、其他)、最终用户(诊所、医院、其他)、分销渠道(医院药房、零售药房、网上药房)、国家(美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太地区(沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区)行业趋势和预测(至 2029 年)

静脉注射(IV)溶液市场

市场分析和洞察全球静脉注射(IV)解决方案市场

静脉注射 (IV) 溶液市场预计将在 2022-2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称,在上述预测期内,市场复合年增长率将达到 6.30%。

静脉 (IV) 溶液包括水、电解质、糖和药物。为了恢复体液量并管理电解质平衡,根据患者的需求、医疗状况、年龄和体型为其注射。它们还常用于静脉治疗,以补充电解质、给药和血液制品,并为血管内液体隔室提供重要营养。

The rise in the prevalence of gastrointestinal disorder and neurological diseases because of unhealthy eating habits act as a major factor driving the market’s growth rate. Additionally, rising healthcare expenditure is the market driver influencing the growth rate of intravenous (IV) solutions market. Furthermore, increasing incidences of infection and rise in the acceptance of vitamin C intravenous solutions for colorectal cancer are the factors that will expand the intravenous (IV) solutions market. Other factors including rise in the growing government initiatives and rising awareness will positively impact the market growth rate. Another significant factor that will cushion the growth of intravenous (IV) solutions market is the increase in number of cases of cancer and diabetes. Also, rise in the level of disposable income and increase in sedentary lifestyle will escalate the market growth rate for the mention forecast period mentioned above. The demand for IV therapy to provide anesthetic, pain medicines, antibiotics, fluids, and other important fluids in patients requiring critical care is increasing and hence increase the need for intravenous (IV) solutions market. 

Moreover, the rise in the research and development activities and increasing product launches will provide beneficial opportunities for the intravenous (IV) solutions market in the forecast period of 2022-2029. Additionally, emerging new market and the improving healthcare infrastructure will act as major markets drivers that will create new opportunities for the markets growth rate.

However, high cost associated with product will impede the market’s growth rate. Also, the increasing number of technical norms and strict policies by regulatory authorities will hamper the intravenous (IV) solutions market’s growth. Lack of awareness will further challenge the intravenous (IV) solutions market in the forecast period mentioned above.

This intravenous (IV) solutions market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the intravenous (IV) solutions market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Intravenous (IV) Solutions Market Scope and Market Size

The intravenous (IV) solutions market is segmented on the basis of type, solution, demographic, bag type, application, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of type, the intravenous (IV) solutions market is segmented into partial parenteral nutrition and total parenteral nutrition.
  • On the basis of solution, the intravenous (IV) solutions market is segmented into saline, dextran, lactated ringer’s, amino acid, vitamins and minerals, heparin and trace elements, and mixed solutions. The saline segment is further sub-segmented into normal saline and hypertonic saline.
  • On the basis of demographic, the intravenous (IV) solutions market is segmented into adult, pediatric and geriatric.
  • On the basis of bag type, the intravenous (IV) solutions market is segmented into large volume bags and small volume bags
  • On the basis of application, the intravenous (IV) solutions market is segmented into basic IV solution, nutritional IV solution, blood IV solution, drug IV solution, irrigation IV solution and others.
  • On the basis of end-users, the intravenous (IV) solutions market is segmented into clinic, hospital and others.

The intravenous (IV) solutions market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Intravenous (IV) Solutions Market Country Level Analysis

Intravenous (IV) solutions market is analyzed and market size information is provided by the country, type, solution, demographic, bag type, application, end-users and distribution channel as referenced above.

The countries covered in the intravenous (IV) solutions market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the intravenous (IV) solutions market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing research and development activities and rising government support in this region.

报告的国家部分还提供了影响单个市场因素和国内市场法规变化,这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。

患者流行病学分析

静脉注射 (IV) 溶液市场还为您提供详细的市场分析,以进行患者分析、预后和治疗。患病率、发病率、死亡率、依从率是报告中提供的一些数据变量。分析流行病学对市场增长的直接或间接影响,以创建更强大和队列多元统计模型,用于预测增长期的市场。

竞争格局和全球静脉注射(IV)解决方案市场份额分析

静脉注射 (IV) 溶液市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对静脉注射 (IV) 溶液市场研究的关注有关。

静脉(IV)溶液市场的一些主要参与者包括 Fresenius SE & Co. KGaA、B. Braun Melsungen AG、ICU Medical, Inc.、Pfizer Inc.、Grifols, SA、Baxter、Terumo Medical Corporation、Ajinomoto Co., Inc.、Otsuka America Pharmaceutical, Inc.、Vifor Pharma Management Ltd.、JW Life Science、Amanta Healthcare、Axa Parenterals Ltd. 和 Salius Pharma Private Limited. 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Intravenous (IV) Solutions Market at a CAGR of 6.30% during the forecast period of 2022 to 2029.
The Global Intravenous (IV) Solutions Market segmented By Application such as Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, Irrigation IV Solution, Others.
This intravenous (IV) solutions market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.
The major players operating in the intravenous (IV) solutions market are Fresenius SE & Co. KGaA, B. Braun Melsungen AG, ICU Medical, Inc., Pfizer Inc., Grifols, S.A., Baxter, Terumo Medical Corporation, Ajinomoto Co., Inc., Otsuka America Pharmaceutical, Inc., Vifor Pharma Management Ltd., JW Life Science, Amanta Healthcare, Axa Parenterals Ltd., and Salius Pharma Private Limited., among others.